Domov › Idiopatická trombocytopenická purpura › Kalifornia
Klinické štúdie Idiopatická trombocytopenická purpura v štáte Kalifornia
10 štúdií pre Idiopatická trombocytopenická purpura hľadá účastníkov v zariadeniach v štáte Kalifornia.
Mestá v štáte Kalifornia
Oficiálny text štúdie (anglicky)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University, Palo Alto
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- MemorialCare Long Beach Medical Center, Long Beach
Prebieha náborFáza 3
Vek 18 až 100 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Usc Norris Comprehensive Cancer Center, Los Angeles
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- City of Hope, Duarte
Prebieha náborFáza 1
Vek 18 až 75 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
Prebieha náborFáza 1
Vek 18 až 85 · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
- University of Southern California (USC), Los Angeles
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Sharp Memorial Hospital, Oceanside
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 5. 2026 · NCT06544499Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.